{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T21:25:25Z","timestamp":1769549125167,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.jns.2016.02.060","type":"journal-article","created":{"date-parts":[[2016,2,28]],"date-time":"2016-02-28T13:25:53Z","timestamp":1456665953000},"page":"97-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Evoked potentials are useful for diagnosis of neuromyelitis optica spectrum disorder"],"prefix":"10.1016","volume":"364","author":[{"given":"Keiko","family":"Ohnari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumasa","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Mafune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2016.02.060_bb0005","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2016.02.060_bb0010","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2016.02.060_bb0015","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"9","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2016.02.060_bb0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jns.2014.03.033","article-title":"Features of anti-aquaporin 4 antibody-seronegative Thai patients with neuromyelitis optica spectrum disorders: a comparison with seropositve cases","volume":"341","author":"Siritho","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2016.02.060_bb0025","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jamaneurol.2014.2137","article-title":"Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders","volume":"72","author":"Flanagan","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jns.2016.02.060_bb0030","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1191\/135248506ms1244oa","article-title":"Early abnormalities of evoked potentials and future disability in patients with multiple sclerosis","volume":"12","author":"Kallmann","year":"2006","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2016.02.060_bb0035","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1177\/1352458514525867","article-title":"Combined visual and motor evoked potentials predict multiple sclerosis disability after 20years","volume":"20","author":"Schlaeger","year":"2014","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2016.02.060_bb0040","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0022-510X(88)90068-8","article-title":"Evoked potential in suspected multiple sclerosis: diagnosis value and prediction of clinical course","volume":"83","author":"Hume","year":"1988","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2016.02.060_bb0045","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1136\/jnnp.2005.086280","article-title":"Multimodel evoked potential to assess the evolution of multiple sclerosis: a longitudinal study","volume":"77","author":"Leocani","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2016.02.060_bb0050","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria\u201d","volume":"58","author":"Polman","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2016.02.060_bb0055","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1007\/s00415-011-6033-x","article-title":"Prognostic value of multimodal evoked potential in multiple sclerosis: the EP score","volume":"258","author":"Invernizzi","year":"2011","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2016.02.060_bb0060","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s10072-011-0862-3","article-title":"Sensory evoked potentials to predict short-term progression of disability in multiple sclerosis","volume":"33","author":"Margaritella","year":"2012","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jns.2016.02.060_bb0065","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/1352458512447597","article-title":"Evaluation of pattern-reversal visual evoked potential in patients with neuromyelitis optica","volume":"19","author":"Neto","year":"2013","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2016.02.060_bb0070","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jns.2009.02.371","article-title":"Multimodality-evoked potential study of anti-aquaporin-4 antibody-positive and -negative multiple sclerosis patients","volume":"281","author":"Watanabe","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2016.02.060_bb0075","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2016.02.060_bb0080","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2016.02.060_bb0085","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/jnnp.26.3.211","article-title":"Cereberal evoked potentials in patients with dissociated sensory loss","volume":"26","author":"Halliday","year":"1963","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2016.02.060_bb0090","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1136\/jnnp-2012-302310","article-title":"Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders","volume":"84","author":"Jacob","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2016.02.060_bb0095","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spestrum disorder","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2016.02.060_bb0100","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1212\/WNL.54.9.1720","article-title":"Practice parameter: the usefulness of evoked potentials in identifying clinically silent lesion in patients with suspected multiple sclerosis (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"54","author":"Groseth","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2016.02.060_bb0105","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1212\/WNL.0000000000001367","article-title":"MRI characteristics of neuromyelitis optica spectrum disorder an international update","volume":"84","author":"Kim","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2016.02.060_bb0110","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1750-3639.2007.00064.x","article-title":"The immunopathology of multiple sclerosis: an overview","volume":"17","author":"Lassmann","year":"2007","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jns.2016.02.060_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113631","article-title":"Clinical correlations of motor and somatosensory evoked potentials in neuromyelitis optica","volume":"9","author":"Tsao","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2016.02.060_bb0120","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.mri.2014.01.023","article-title":"Diffusion tensor imaging of the cervical spinal cord of patients with neuromyelitis optica","volume":"32","author":"Rivero","year":"2014","journal-title":"Magn. Reson. Imaging"},{"key":"10.1016\/j.jns.2016.02.060_bb0125","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/jmri.22575","article-title":"Quantitative assessment of the cervical spinal cord damage in neuromyelitis optica using diffusion tensor imaging at 3Tesla","volume":"33","author":"Qian","year":"2011","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.jns.2016.02.060_bb0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/brain\/100.1.19","article-title":"Abnormalities of the auditory evoked potentials in patients with multiple sclerosis","volume":"100","author":"Robinson","year":"1977","journal-title":"Brain"},{"key":"10.1016\/j.jns.2016.02.060_bb0135","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1016\/j.jocn.2014.04.019","article-title":"Audiological evidence of therapeutic effect of steroid treatment in neuromyelitis optica with hearing loss","volume":"21","author":"Takanashi","year":"2014","journal-title":"J. Clin. Neurosci."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X16301241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X16301241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T15:59:19Z","timestamp":1536940759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X16301241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":27,"alternative-id":["S0022510X16301241"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2016.02.060","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evoked potentials are useful for diagnosis of neuromyelitis optica spectrum disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2016.02.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}